Loopbaan van Bonabes-Olivier de Rougé
Eerdere bekende functies van Bonabes-Olivier de Rougé
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Directeur/Bestuurslid | 22-03-2006 | 08-04-2011 |
| Hoofd Techniek/Wetenschap/O&O | 22-03-2006 | 08-04-2011 | |
| Cellpep SA | President | - | 21-04-2006 |
Statistieken
Internationaal
| Canada | 2 |
| Frankrijk | 2 |
Operationeel
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| President | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
| Cellpep SA | Health Technology |
